Microbiome Insights is a high growth, revenue-stage company that has established itself as a global leader in the microbiome testing market. The company has developed a microbiome-based chronic disease management platform and is launching its first proprietary product to help IBD patients manage their disease. This test will also be marketed to pharma as clinical development biomarker for IBD drug development.